$TSLA is rock-solid at support!
$600+ is coming FASTER than you think
Still sleeping on it?
Your target: $600, $700, or moon?
Drop it below + like/RT!
#TSLA#Tesla#BullRun
$AAPL down 1.1% as GOOGL steals crown — iPhone sales flat, AI lag hurting.
2026 prediction: Vision Pro refresh + services growth could push +15-20%, but needs China rebound.
Apple rebound or dethroned?
#AAPL#Apple#TechRotation
$GOOGL overtakes $AAPL in market cap for first time since 2019.
Alphabet's AI/Gemini push + ad rev +20% YoY = 2026 upside to $250+.
Apple lags on innovation.
GOOGL the new king?
#GOOGL#Alphabet#TechGiants
$NVDA drops 2.2% as tech rotates out — still +180% YTD on AI dominance.
2026 forecast: rev +50% to $200B+ if Blackwell ramps.
But valuation 60x fwd — bubble or buy?
AI forever or correction coming?
#NVDA#AI#TechSelloff
Shiller PE opens 2026 at 41 — highest since 2000 dot-com peak.
Both prior 40+ readings → -50% and -89% drawdowns.
Bonds screaming, gold at ATH, yields rising.
Is this the final melt-up or the top?
#SPX#ShillerPE#Markets
$TSLA starts 2026 above $500 after 5-year base breakout.
Same pattern:
2020 → +1400%
2023 → +350%
Measured move $700–900 this cycle.
Robotaxi year begins.
Bull or bear on $TSLA 2026?
#TSLA#Elon#EV
⚡ Breaking: Adequate margin of safety today, high-quality blue-chips with intrinsic value undervalued in current market. Leaders: MSFT, AAPL, JPM. Time to adjust your portfolio? What's your strategy? #Stocks#ValueInvesting#Investing#WarrenBuffett
📊 Analysis: Covered Call strategy locking gains today, Theta decay bringing additional income in current market. Top picks: VIX, IWM, GLD. Are you positioning correctly? Let's discuss! #Puts#Options#RiskManagement#OptionsTrading
💡 Insight: Hydrogen policy benefits emerging today, energy storage demand surging in current quarter driving green energy transition. Watch: ENPH, BLDP, SEDG. Strategy question: Bullish or bearish? Your thoughts? #GreenEnergy#Solar#TSLA#EnergyStocks
⚡ Breaking: Gene editing clinical trials achieve breakthroughs, precision medicine commercialization accelerating. Leaders: MRNA, UNH, JNJ. Time to adjust your portfolio? What's your strategy? #Biotech#PFE#Pharma#MRNA